%Doonited News: Latest Updates % Archives

DRL Q4 FY25 Results: PAT, EBITDA grow by one-fifth, beat Street estimates; drug maker declares dividend

Posted by News Desk Doonited
|Date: May 10, 2025

DRL Q4 FY25 Results: PAT, EBITDA grow by one-fifth, beat Street estimates; drug maker declares dividend

Dr Reddy's Labs Q4 FY25 Earnings: Hyderabad-based drug maker Dr Reddy's Laboratories (DRL) on Friday repo ...

Dr Reddy's Labs Q4 FY25 Earnings: Hyderabad-based drug maker Dr Reddy's Laboratories (DRL) on Friday reported a consolidated net profit of Rs 1,593.9 crore for the quarter ended March 31, an increase ...

May 10, 2025
| by News Desk Doonited

Read more